Journal of Leukocyte Biology, Vol 62, Issue 4 535-546, Copyright © 1997 by Society for Leukocyte Biology
JOURNAL ARTICLE |
AL Hall, BS Wilson, JR Pfeiffer, JM Oliver and LA Sklar
Cancer Research and Treatment Center and Department of Pathology, University of New Mexico School of Medicine, Albuquerque 87131, USA.
The human formyl peptide receptor (FPR) expressed in RBL-2H3 transfectants (RBL[FPR]) behaves qualitatively like the FPR expressed by neutrophils except that it causes sustained F-actin accumulation and cell shape change responses on formyl peptide stimulation. These sustained responses were not accounted for by changes in the transfected receptor's ability to interact with ligand or by receptor density. Signal transduction pathways of transfected and neutrophil FPRs are apparently similar. In transfected cells, dissociation of ligand is sensitive to guanine nucleotide, the G protein is pertussis toxin-sensitive, FPR and G protein appear to be precoupled, the F-actin response is stimulated with the same dose-response profile as in neutrophils, and the F-actin accumulation response is directly regulated by the FPR, even long after initial stimulation. Potentially significant differences between neutrophil and transfected FPR were found when receptor processing was measured. In neutrophils, practically 100% of the FPR is converted to forms that dissociate slowly from ligand and are inactive in signal transduction within 2 min of ligand stimulation. By contrast, 20% or more of transfected FPR remains rapidly dissociating even 5 min after stimulation. Although 80% of neutrophil FPR is internalized by 5 min after stimulation, transfected FPR appears to plateau at 50-60% internalized. Because actin responses in neutrophils are regulated by a small number of active receptors, the inefficiency of receptor inactivation in RBL(FPR) transfectants may account for the prolonged F-actin accumulation response.
This article has been cited by other articles:
 |
|
 |
|
  M. V. Carriero, I. Longanesi-Cattani, K. Bifulco, O. Maglio, L. Lista, A. Barbieri, G. Votta, M. T. Masucci, C. Arra, R. Franco, et al. Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis Mol. Cancer Ther., September 1, 2009; 8(9): 2708 - 2717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xue, G. Hsieh, M. A. Raymond-Stintz, J. Pfeiffer, D. Roberts, S. L. Steinberg, J. M. Oliver, E. R. Prossnitz, D. S. Lidke, and B. S. Wilson Activated N-Formyl Peptide Receptor and High-Affinity IgE Receptor Occupy Common Domains for Signaling and Internalization Mol. Biol. Cell, April 1, 2007; 18(4): 1410 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. He, D. D. Browning, and R. D. Ye Differential Roles of the NPXXY Motif in Formyl Peptide Receptor Signaling J. Immunol., March 15, 2001; 166(6): 4099 - 4105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Miettinen, J. Gripentrog, and A. Jesaitis Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin J. Cell Sci., June 8, 2000; 111(14): 1921 - 1928. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Geijsen, S. van Delft, J. A.M. Raaijmakers, J.-W. J. Lammers, J. G. Collard, L. Koenderman, and P. J. Coffer Regulation of p21rac Activation in Human Neutrophils Blood, August 1, 1999; 94(3): 1121 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Bowman, J. J. Campbell, K. M. Druey, A. Scheschonka, J. H. Kehrl, and E. C. Butcher Regulation of Chemotactic and Proadhesive Responses to Chemoattractant Receptors by RGS (Regulator of G-protein Signaling) Family Members J. Biol. Chem., October 23, 1998; 273(43): 28040 - 28048. [Abstract] [Full Text] [PDF]
|
|
